PHIL, Inc. · 1 month ago
Pharmacist - Part Time
PHIL is a Series D health-tech startup focused on improving the prescription management process. They are seeking a licensed Pharmacist in Arizona to ensure high-quality dispensing of specialty medications while supporting pharmacy operations and patient safety.
BiotechnologyMedicalSoftware
Responsibilities
Verifying prescriptions for accuracy, completeness, and compliance with regulatory requirements
Counseling patients when necessary to ensure safe and effective medication use
Reviewing patient records and medication histories to identify potential drug interactions or safety concerns
Collaborating with pharmacy technicians and operations staff to ensure efficient prescription fulfillment
Maintaining accurate records in accordance with state and federal guidelines
Participating in quality assurance and continuous improvement efforts within the pharmacy
Supporting pharmacy operations in alignment with PHIL’s mission to improve patient access to care
Qualification
Required
Bachelor's degree in Pharmacy or Doctor of Pharmacy (PharmD)
Active and unrestricted Arizona pharmacist license in good standing
1–3 years of experience in a retail, specialty, or mail-order pharmacy setting
Deep knowledge of state and federal pharmacy laws and regulations
Strong attention to detail and a commitment to patient safety
Ability to work part-time 4-6 hours up to 5 days per week. With a preference for afternoon and evening shifts
Preferred
Familiarity with prescription fulfillment systems and electronic health records (EHR)
Experience with specialty medications or chronic disease management
Benefits
Full benefits (medical, dental, vision)
401(k) contribution opportunity
Company
PHIL, Inc.
PHIL helps pharmaceutical brands improve patient access, provider engagement, and brand outcomes through innovative technology and dedicated support.
Funding
Current Stage
Late StageTotal Funding
$181.6MKey Investors
K2 HealthVenturesWarburg PincusTarsadia Investments
2025-07-08Debt Financing· $60M
2021-11-17Series Unknown
2021-06-03Series D· $56M
Recent News
2025-07-10
Company data provided by crunchbase